Literature DB >> 1491034

High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine.

M R Stratford1, M F Dennis.   

Abstract

A high-performance liquid chromatographic method is described which enables the determination of nicotinamide and eight of its possible metabolites in human and murine plasma and urine, using ion-pairing on a base-deactivated reversed-phase column. Calibration curves were linear up to 2 mumol/ml for nicotinamide and 200 nmol/ml for the metabolites; both the intra- and inter-assay relative standard deviations ranged between 1 and 8%. In murine plasma, the N-oxide was the major nicotinamide metabolite, but in man, formation of 1-methylnicotinamide and the 2- and 4-pyridones was also significant. In urine, nicotinuric acid was seen in the mouse, but no nicotinic acid metabolites were seen in man.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491034     DOI: 10.1016/0378-4347(92)80313-f

Source DB:  PubMed          Journal:  J Chromatogr


  11 in total

1.  A method for comprehensive analysis of urinary acylglycines by using ultra-performance liquid chromatography quadrupole linear ion trap mass spectrometry.

Authors:  Avalyn E Lewis-Stanislaus; Liang Li
Journal:  J Am Soc Mass Spectrom       Date:  2010-09-18       Impact factor: 3.109

2.  Individual variability in human blood metabolites identifies age-related differences.

Authors:  Romanas Chaleckis; Itsuo Murakami; Junko Takada; Hiroshi Kondoh; Mitsuhiro Yanagida
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

3.  The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma.

Authors:  Ewa M Slominska; Przemyslaw Rutkowski; Ryszard T Smolenski; Andrzej Szutowicz; Boleslaw Rutkowski; Julian Swierczynski
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

4.  Nicotinamide N-oxidation by CYP2E1 in human liver microsomes.

Authors:  Alexander Michael Real; Shangyu Hong; Pavlos Pissios
Journal:  Drug Metab Dispos       Date:  2012-12-21       Impact factor: 3.922

5.  Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure.

Authors:  Ewa M Slominska; Ryszard T Smolenski; Marek Szolkiewicz; Neil Leaver; Boleslaw Rutkowski; H Anne Simmonds; Julian Swierczynski
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

6.  Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure.

Authors:  Ewa M Slominska; Katarzyna Kowalik; Ryszard T Smolenski; Marek Szolkiewicz; Przemyslaw Rutkowski; Boleslaw Rutkowski; Julian Swierczynski
Journal:  Pediatr Nephrol       Date:  2006-04-08       Impact factor: 3.714

7.  Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.

Authors:  M R Stratford; M F Dennis
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  Cell Culture Medium Formulation and Its Implications in Cancer Metabolism.

Authors:  Tobias Ackermann; Saverio Tardito
Journal:  Trends Cancer       Date:  2019-05-29

9.  Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.

Authors:  A Rojas; R J Hodgkiss; M R Stratford; M F Dennis; H Johns
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

10.  Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoring.

Authors:  M R Stratford; M F Dennis; P Hoskin; H Phillips; R J Hodgkiss; A Rojas
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.